Visionary Wealth Advisors decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 27,758 shares of the medical research company’s stock after selling 263 shares during the quarter. Visionary Wealth […]
Left Brain Wealth Management LLC boosted its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,013 shares of the medical research company’s stock after purchasing an additional 39 shares during the period. […]
/PRNewswire/ DelveInsight s Anti-Radiation Drugs Market Insights report provides the current and forecast market analysis, individual leading anti-radiation.
The rise in demand for anti-radiation drugs is mainly driven by several factors. These include the growing occurrence of side effects linked to cancer screening methods, heightened risks of
Caxton Associates LP lifted its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 282.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,279 shares of the medical research company’s stock after purchasing an additional 9,804 shares during […]